[ASAP] The BET Bromodomain Inhibitor OTX015 Synergizes with Targeted Agents in Multiple Myeloma

Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.8b00880

Source: Molecular Pharmaceutics - October 19, 2018 Category: Drugs & Pharmacology Authors: Jie Gu, Sha Song, Huiying Han, Hongxia Xu, Gao Fan, Chen ’ao Qian, Yingchun Qiu, Wenqi Zhou, Wenzhuo Zhuang, Bingzong Li Source Type: research